» Articles » PMID: 39684547

Gut Microbiota-microRNA Interactions and Obesity Pathophysiology: A Systematic Review of Integrated Studies

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Dec 17
PMID 39684547
Authors
Affiliations
Soon will be listed here.
Abstract

Obesity is the fifth leading cause of death globally and its comorbidities put a high burden on societies and cause disability. In this review, we aim to summarize the interactions and crosstalk between gut microbiota and micro-RNA (miRNA) in obesity. We searched for the relevant literature through PubMed, Web of Science, Scopus, and Science Direct. The study design is registered in the international prospective register of systematic reviews (Prospero). According to the inclusion criteria, eight studies were eligible for assessment (two studies including human subjects and six studies including animal subjects). We report that the interactions of miRNA and gut microbiota in the context of obesity are diverse and in some cases tissue specific. However, the interactions mediate obesity-associated pathways including the inflammatory response, oxidative stress, insulin signaling, gut permeability, and lipogenesis. To mention the most meaningful results, the expression of adipose tissue miRNA-378a-3p/5p was associated with and abundance, the expression of hepatic miRNA-34a was related to the phylum, and the expression of miRNA-122-5p and miRNA-375 was associated with the genus. miRNA-microbiota-associated pathological pathways seem to provide an intricate, but promising field for future research directed toward the treatment of obesity and its comorbidities.

Citing Articles

Microbiota-derived extracellular vesicles: current knowledge, gaps, and challenges in precision nutrition.

Marquez-Paradas E, Torrecillas-Lopez M, Barrera-Chamorro L, Del Rio-Vazquez J, Gonzalez-de la Rosa T, Montserrat-de la Paz S Front Immunol. 2025; 16:1514726.

PMID: 40051622 PMC: 11882860. DOI: 10.3389/fimmu.2025.1514726.

References
1.
Wortelboer K, Bakker G, Winkelmeijer M, van Riel N, Levin E, Nieuwdorp M . Fecal microbiota transplantation as tool to study the interrelation between microbiota composition and miRNA expression. Microbiol Res. 2022; 257:126972. DOI: 10.1016/j.micres.2022.126972. View

2.
Liu S, Weiner H . Control of the gut microbiome by fecal microRNA. Microb Cell. 2017; 3(4):176-177. PMC: 5349091. DOI: 10.15698/mic2016.04.492. View

3.
Martin-Gallausiaux C, Marinelli L, Blottiere H, Larraufie P, Lapaque N . SCFA: mechanisms and functional importance in the gut. Proc Nutr Soc. 2020; 80(1):37-49. DOI: 10.1017/S0029665120006916. View

4.
Jasirwan C, Lesmana C, Hasan I, Sulaiman A, Gani R . The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms. Biosci Microbiota Food Health. 2019; 38(3):81-88. PMC: 6663510. DOI: 10.12938/bmfh.18-032. View

5.
Wang L, Wan Y . The role of gut microbiota in liver disease development and treatment. Liver Res. 2020; 3(1):3-18. PMC: 7251939. DOI: 10.1016/j.livres.2019.02.001. View